The Food and Drug Administration said Thursday it will ask its outside experts to meet in late November to scrutinize Merck’s pill to treat COVID-19. The Nov. 30 meeting means U.S. regulators almost...

Experts working in the field of vaccine development tend to believe that an effective vaccine is not likely to be available for the general public before the fall of 2021. In a paper published this week...

A second wave of the new coronavirus is unlikely in Denmark as the reproduction rate has stayed below a key threshold since restrictions were eased a month ago, a top health expert said Tuesday. The reproduction...